Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Global Review of National Cancer Control Plans Highlights Progress and Opportunities of National Cancer Strategies

A quote that reads “National cancer control plans are an opportunity to integrate current scientific knowledge into global cancer control policies and practice." The attribution reads “Dr. Satish Gopal, Director, NCI Center for Global Health”. The text is white on a blue background.
Enlarge Image

In 2023, the International Cancer Control Partnership (ICCP) conducted a global review of 156 national cancer control plans (NCCPs) to better understand the current landscape of cancer control strategies, across countries with varying levels of income. Vital to reducing the global burden of cancer, NCCPs address cancer risk factors, access to screening, and workforce training. ICCP’s last global review was conducted in 2018. However, as cancer research, treatments, and policies have changed worldwide, up-to-date information on the status and content of NCCPs was needed – particularly in the wake of the COVID-19 pandemic. Learn more about the highlights and key findings of ICCP's global review, “The changing global landscape of national cancer control plans,” out now in The Lancet Oncology. 

ICCP brings together organizations to coordinate efforts in support of countries as they develop and implement evidence-based NCCPs. ICCP is co-convened by the NCI Center for Global Health and the Union for International Cancer Control. 

Email